Home/Filings/4/0000943819-25-000171
4//SEC Filing

Sandercock Brett 4

Accession 0000943819-25-000171

CIK 0000943819other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 10:45 AM ET

Size

4.6 KB

Accession

0000943819-25-000171

Insider Transaction Report

Form 4
Period: 2025-11-20
Sandercock Brett
Chief Financial Officer
Transactions
  • Award

    ResMed Common Stock

    2025-11-20+2,71088,495 total
Footnotes (1)
  • [F1]Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on November 20, 2025, when the compensation and leadership development committee certified that the performance metrics were met.

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1
  • filerCIK 0001346064

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 10:45 AM ET
Size
4.6 KB